1、中文文献

[1]黄依婷,磨宁芳,李妞妞,等. 基于网络药理学和分子对接的逍遥散治疗肝癌并抑郁症的潜在机制探讨 [J]. 药物评价研究, 2024, 47 (06): 1175-1186.

[2]曾碧雨,姚春,陈月桥,等. 中医药治疗乙型肝炎肝硬化失代偿期研究进展 [J]. 陕西中医, 2024, 45 (06): 850-854.

[3]向雅洁,刘洋洋,冯剑,等. 经典名方中鸡血藤的本草考证 [J/OL]. 中国实验方剂学杂志, 1-12[2024-07-04].

[4]刘晓明,程金来,黎如霜,等. 加味逍遥散通过外泌体miRNA途径发挥抗肝癌作用 [J/OL]. 中国组织工程研究, 1-11[2024-07-04].

[5]袁行勇,姚春,陈炜,等. 阿尔茨海默病不同治疗方式研究新进展 [J]. 广州医药, 2024, 55 (03): 236-244.

[6]黄良江,毛德文,郑景辉,等. 人工智能在肝性脑病风险预测模型中的应用进展 [J]. 实用医学杂志, 2024, 40 (03): 289-294.

[7]吴丽萍,王清碧,姚春,等. 基于脑肠轴探讨针灸治疗脑卒中后失眠作用机制 [J]. 辽宁中医药大学学报, 2024, 26 (06): 125-129. DOI:10.13194/j.issn.1673-842x.2024.06.025.

[8]王涵,陈玮钰,付蕾,等. 组蛋白赖氨酸特异性去甲基化酶KDM1家族在肝细胞癌中的作用 [J]. 中西医结合肝病杂志, 2023, 33 (11): 1052-1056.

[9]王晋平,姚春,邢远,等. 三焦阳化胶囊干预轻度认知障碍临床研究 [J]. 广西中医药大学学报, 2023, 26 (06): 1-7.

[10]阮子芸,张广发,王涵,等. 加味逍遥散调控HPA-HPG轴对不同性别抑郁模型大鼠的影响 [J]. 神经解剖学杂志, 2023, 39 (05): 568-574.

[11]黎如霜,刘晓明,夏猛,等. 柴胡加龙骨牡蛎汤加减治疗不寐临床观察 [J]. 广西中医药大学学报, 2023, 26 (05): 14-16.

[12]张广发,蔡颖莹,林龙,等. 基于PI3K/AKT/mTOR信号通路探讨大黄煎剂对轻微型肝性脑病大鼠脑组织炎症损伤的保护机制 [J]. 临床肝胆病杂志, 2024, 40 (02): 312-318.

[13]姚春. 基于“药食同源”理论的八桂天龙散防治老年痴呆的机理探析 [J]. 广西中医药, 2023, 46 (04): 40-43.

[14]李丽琴,莫雪妮,袁莉,等. 温阳复元方对脑缺血再灌注损伤大鼠线粒体铁死亡相关蛋白IRP1和FAM96A表达的影响 [J]. 现代中西医结合杂志, 2023, 32 (15): 2045-2050+2059.

[15]黄良江,毛德文,张荣臻,等. 中医药调控程序性细胞死亡干预肝纤维化的研究进展 [J]. 临床肝胆病杂志, 2024, 40 (01): 161-168.

[16]袁莉,邓秋媚,向军军,等. miR-137通过调控血红素铁输出蛋白FLVCR、BCRP对大鼠I/R损伤的保护作用 [J]. 西部医学, 2023, 35 (06): 787-792.

[17]姚春,林龙,王萌,等. 基于生物信息学、网络药理学与分子对接研究八桂天龙散治疗阿尔茨海默病的机制 [J]. 中华中医药学刊, 2023, 41 (06): 1-5+259-263.

[18]柏文婕,潘佩佩,石清兰,等. 基于“浊毒致病”学说探讨肝性脑病病因病机 [J]. 中国中医基础医学杂志, 2023, 29 (05): 727-730.

[19]袁莉,向军军,李丽琴,等. miR-335通过调控铁死亡对大鼠脑缺血/再灌注损伤的保护作用及机制研究 [J]. 实用心脑肺血管病杂志, 2023, 31 (05): 55-61.

[20]杜沅沁,王萌,黄国初,等. 基于胆汁酸代谢组学探讨复方大黄煎剂保留灌肠对轻微型肝性脑病大鼠模型的治疗作用 [J]. 临床肝胆病杂志, 2023, 39 (10): 2348-2357.

[21]姚春. 新时期中医经典课程建设探索 [J]. 医学教育研究与实践, 2023, 31 (02): 184-189.

[22]姚春. 中医经典课程建设刍议 [J/OL]. 医学教育研究与实践, 1-8[2024-07-04].

[23]韦义展,王春玲,姚春,等. 桂派中医学术思想融入《伤寒论》课程教学探讨 [J]. 中医药管理杂志, 2023, 31 (05): 10-12.

[24]石清兰,黄祖鸿,柏文婕,等. 肝性脑病“四步曲”防治策略的构建与实践 [J]. 中西医结合肝病杂志, 2023, 33 (02): 166-168.

[25]王春玲,区锏,姚春,等. “桂派杏林师承”班人才培养的探索与实践 [J]. 广西中医药大学学报, 2023, 26 (01): 65-68.

[26]王萌,姚春,黄国初. 提高中医临床教师教学基本功创新策略探讨 [J]. 教育教学论坛, 2022, (50): 17-20.

[27]冯秋瑜,王春玲,姚春.将瑶医特色融入广西中医药大学中医学专业教学的思考[J].广西中医药大学学报,2022,25(05):74-77.

[28]姚春,张广发,乐滢玉,毛德文,张荣臻,刘茵.鞘磷脂酶在肝细胞癌中的作用[J].临床肝胆病杂志,2022,38(02):461-465.（中文核心）

[29]姚春,王萌,孙玉浩,姚凡,夏猛,黄良江.基于网络药理学分析柴胡加龙骨牡蛎汤治疗不寐的作用机制[J].广西中医药大学学报,2022,25(01):1-8.

[30]林镛,颜耿杰,冯逢,彭子明,龙富立,韦艾凌,王明刚,姚春.胆固醇与肝再生关系及其在肝衰竭治疗中的意义和潜在价值[J].临床肝胆病杂志,2022,38(03):708-713.（中文核心，通讯作者）

[31]胡跃强,向军军,邓秋媚,吴林,莫雪妮,陈炜,姚春.Rho激酶抑制剂介导Rho A/ROCK2通路对VaD大鼠海马神经元的保护机制[J].中风与神经疾病杂志,2021,38(12):1060-1063.（科核，通讯作者）

[32]邱华,范春娇,苏翠丽,黄鹏,刘雪梅,李旺,蒙荫杰,何锦轶,毛德文,姚春.白花香莲解毒颗粒制备工艺研究[J].中国现代应用药学,2021,38(23):2921-2925.（中文核心，通讯作者）

[33]邱华,范春娇,苏翠丽,黄鹏,刘雪梅,李旺,蒙荫杰,何锦轶,毛德文,姚春.白花香莲解毒颗粒制备工艺研究[J].中国现代应用药学,2021,38(23):2921-2925.（中文核心，通讯作者）

[34]姚春.在第五届壮瑶药协同创新高端学术论坛上的讲话[J].壮瑶药研究,2021(01):1-2.

[35]庞娣,姚春,付蕾,王萌,姚凡,李开富,杨燕唯,金婷.大黄煎剂保留灌肠治疗肝性脑病疗效的Meta分析[J].湖南中医杂志,2020,36(07):127-132.

[36]李开富,蒋燕丽,庞娣,姚凡,王萌,黄国初,姚春.轻微型肝性脑病中西医治疗探讨[J].大众科技,2019,21(09):54-56.

[37]罗莉芬,姚春,何智豪,姚凡,王萌,黄国初,钟宇,杨小徽,李开富,庞娣.轻微型肝性脑病肠道菌群失调中西医治疗探讨[J].辽宁中医药大学学报,2019,21(06):124-127

[38]罗莉芬,姚春,杨小徽,姚凡,王萌.通腑开窍法治疗轻微型肝性脑病探讨[J].山东中医药大学学报,2018,42(05):387-389.

[39]韦波,姚春,杨积军,陈世东,李建忠,刘展华,莫纯,周芳华,冯唯,唐文,蒋超,覃艳淑,冯启明.2016—2017年广西食品安全风险会商工作调查[J].应用预防医学,2018,24(04):258-260.

[40]杨小徽,黄国初,王萌,姚凡,钟宇,姚春.大黄煎剂保留灌肠治疗轻微型肝性脑病[J].吉林中医药,2016,36(12):1220-1222.

[41]黄国初,王萌,杨小徽,姚凡,钟宇,姚春.大黄煎剂保留灌肠对轻微型肝性脑病患者血清代谢物谱的影响[J].中医杂志,2016,57(03):220-223

[42]黄国初,王萌,杨小徽,姚凡,钟宇,姚春.基于GC-TOFMS和UPLC-QTOFMS代谢组学分析平台对轻微型肝性脑病特异性代谢物谱的分析[J].临床肝胆病杂志,2016,32(01):139-142.

[43]王萌,黄国初,姚春,张宜男,钟宇,杨小徽.基于气液双相-质谱联用技术对轻微型肝性脑病患者血清代谢物谱的分析[J].中西医结合肝病杂志,2015,25(06):328-330+381.

[44]钟宇,姚春,姚凡,黄国初,王萌,杨小徽.29例轻微型肝性脑病患者血清中特异性代谢物[J8.世界华人消化杂志,2015,23(34):5452-5457.

[45]姚春,王萌,姚凡,邱华,黄国初,牛登峰,张玉娥.解毒化瘀方对轻微型肝性脑病患者智力测验及神经电生理学改变的临床观察[J].时珍国医国药,2014,25(04):890-892.

[46]姚春,姚凡,赵晓芳,谢武,李娜,韦玉仙,何燕,付蕾.橘皮竹茹汤对胆汁返流胃炎大鼠模型的防治作用及对胃泌素、PGE_2含量的影响[J].时珍国医国药,2014,25(01):44-46.

[47]姚春,姚凡,谢武,何燕,韦玉仙,付蕾.大黄煎剂保留灌肠治疗轻微肝性脑病临床研究[J].辽宁中医杂志,2013,40(03):474-476.

[48]姚春,黄伟贞,陈国忠,朱永苹,梁雪,彭卓嵛,付蕾.七方胃痛散对胃溃疡患者溃疡愈合质量影响的临床研究[J].临床医药实践,2012,21(07):483-485.

[49]姚春,张伯礼.中医药对轻微型肝性脑病代谢组学影响的研究现状[J].广西医学,2012,34(06):768-770.

2、外文文献

[1]Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu NH, Zhou Z, Bao Y, Jia W,

Nicholson JK, Jia W. The footprints of gut microbial-mammalian co-metabolism. J

Proteome Res. 2011，10(12):5512-22.

[2] Yao Chun,Tang Nong,Xie Guoxiang,Zheng Xiaojiao,Liu Ping,Fu Lei,Xie Wu,Yao Fan,Li Houkai,Jia Wei. Management of hepatic encephalopathy by traditional chinese medicine.[J]. Evidence-based complementary and alternative medicine : eCAM,2012,2012:835686.

[3] Xie Guoxiang,Zhao Aihua,Zhao Linjing,Chen Tianlu,Chen Huiyuan,Qi Xin,Zheng Xiaojiao,Ni Yan,Cheng Yu,Lan Ke,Yao Chun,Qiu Mingfeng,Jia Wei. Metabolic fate of tea polyphenols in humans.[J]. Journal of proteome research,2012，11(6):3449-57.

[4] Chun Yao,Guochu Huang,Meng Wang,Meng Xia,Fan Yao,Dengfeng Niu,Yuer Zhang,Shan Li,Yu Zhong. Chinese herbal medicine formula Jieduhuayu granules improves cognitive and neurophysiological functions in patients with cirrhosis who have minimal hepatic encephalopathy: A randomized controlled trial[J]. Complementary Therapies in Medicine,2014,22(6):977-85.

[5] Xia Meng,Liu Dan,Yao Chun. TRPC3: A New Target for Therapeutic Strategies in Chronic Pain-DAG-mediated Activation of Non-selective Cation Currents and Chronic Pain (Mol Pain 2014;10:43).[J]. Journal of neurogastroenterology and motility,2015,21(3):445-7.

[6] Xia M, Liu D, Yao C. TRPC3: A New Target for Therapeutic Strategies in Chronic Pain-DAG-mediated Activation of Non-selective Cation Currents and Chronic Pain (Mol Pain 2014;10:43). J Neurogastroenterol Motil. 2015，21(3):445-7.

[6]Wang Xiaoning,Xie Guoxiang,Zhao Aihua,Zheng Xiaojiao,Huang Fengjie,Wang Yixing,Yao Chun,Jia Wei,Liu Ping. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.[J].Journal of proteome research,2016,15(4):1126-34.

[7]Guoxiang Xie,Xiaoning Wang,Runqiu Jiang,Aihua Zhao,Jingyu Yan,Xiaojiao Zheng,Fengjie Huang,Xinzhu Liu,Jun Panee,Cynthia Rajani,Chun Yao,Herbert Yu,Weiping Jia,Beicheng Sun,Ping Liu,Wei Jia. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure[J]. EBioMedicine,2018,37:294-306.

[8]Yao C, Liu L, Xia M, Lv J. A New Analysis for Old Problem of Bile Reflux. J Neurogastroenterol Motil. 2022,28(2):330-331.

[9]Huang G, Xie S, Wang M, Mao D, Huang G, Huang J, Liu X, Zhang R, Xie J, Huang LJ, Cheng C, Yao F, Zhong Y, Lin L, Yao C. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. Biomed Chromatogr. 2023,37(1):e5529.

[10]Liu J, Yao C, Wang Y, Zhao J, Luo H. Non-drug interventions of traditional Chinese medicine in preventing type 2 diabetes: a review. Chin Med. 2023;18(1):151. Published 2023 Nov 14. doi:10.1186/s13020-023-00854-1

[11]Chen Z, Vong CT, Zhang T, Yao C, Wang Y, Luo H. Quality evaluation methods of chinese medicine based on scientific supervision: recent research progress and prospects. Chin Med. 2023;18(1):126. Published 2023 Sep 30. doi:10.1186/s13020-023-00836-3

[12]Guo J, Yan S, Jiang X, et al. Advances in pharmacological effects and mechanism of action of cinnamaldehyde. Front Pharmacol. 2024;15:1365949. Published 2024 Jun 6. doi:10.3389/fphar.2024.1365949

[13]Liang X, Gao H, Xiao J, et al. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma. Front Immunol. 2023;14:1185985. Published 2023 May 24. doi:10.3389/fimmu.2023.1185985

[14]Sun K, Yuan R, He J, et al. Sugarcane leaf polysaccharide exerts a therapeutic effect on cardiovascular diseases through necroptosis. Heliyon. 2023;9(11):e21889. Published 2023 Nov 4.

[15]Guo J, Yan S, Jiang X, Su Z, Zhang F, Xie J, Hao E, Yao C. Advances in pharmacological effects and mechanism of action of cinnamaldehyde. Front Pharmacol. 2024 Jun 6;15:1365949.